Inflammation, ageing and diseases of the lung: Potential therapeutic strategies from shared biological pathways

Abstract

Lung diseases disproportionately affect elderly individuals. The lungs form a unique environment: a highly elastic organ with gaseous exchange requiring the closest proximity of inhaled air containing harmful agents and the circulating blood. The lungs are highly susceptible to senescence, with age and ‘inflammageing’ creating a pro‐inflammatory environment with a reduced capacity to deal with challenges. While lung diseases may have disparate causes, the burden of ageing and inflammation provides a common process that can exacerbate seemingly unrelated pathologies. However, these shared pathways may also provide a common route to treatment, with increased interest in drugs that target ageing processes across respiratory diseases. In this review, we will examine the evidence for the increased burden of lung disease in older adults, the structural and functional changes seen with advancing age and assess what our expanding knowledge of inflammation and ageing pathways could mean for the treatment of lung disease. LINKED ARTICLES This article is part of a themed issue on Inflammation, Repair and Ageing. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.9/issuetoc

TIM-3 on myeloid cells promotes pulmonary inflammation through increased production of galectin-3

“…Lung inflammation is a hallmark of most lung diseases, including acute lung injury, viral infectious pulmonary diseases, chronic airway pulmonary disease, and lung cancer 15,40 . It is a natural protective response to harmful stimuli, such as pathogens, damaged cells, and toxic agents.…”

Pulmonary Diseases in Older Patients: Understanding and Addressing the Challenges

“…Additionally, the presence of multiple comorbidities such as cardiovascular disease, diabetes, and musculoskeletal disorders can complicate the clinical picture, leading to overlapping symptoms and diagnostic challenges [ 12 ]. The age-related decline in lung function and muscle strength exacerbates symptoms and impairs the ability to effectively clear respiratory secretions, increasing susceptibility to infections like pneumonia and exacerbations of chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma [ 6 , 7 , 13 ].…”

Back to the Basics: Usefulness of Naturally Aged Mouse Models and Immunohistochemical and Quantitative Morphologic Methods in Studying Mechanisms of Lung Aging and Associated Diseases

“…Inflammaging is an age-dependent chronic increase in basal systemic inflammation [31,32]. Inflammaging, along with other alterations, may predispose to the development of lung diseases in aged individuals, such as malignancies, COPD, autoimmunity and infectious diseases, and interstitial pneumonia [33].…”